Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928182 · ClinicalTrials.gov registry record · NA
El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham
A NA study of ADHD and Psychiatric Health, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05928182: Completed NA study of ADHD and Psychiatric Health, sponsored by Duke University.
NCT05928182 is a NA study of ADHD and Psychiatric Health that has completed, run by Duke University. The registered enrollment target is 32 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05928182, a NA study of ADHD and Psychiatric Health, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Study team members from El Futuro in Durham, North Carolina have created an intervention called El Faro. El Faro helps Latinx families of children with ADHD understand and cope with the stress and difficulties presented by the disorder. We propose to develop a community-engaged research partnership between El Futuro and the Duke ADHD Program that aims to pilot-test an adapted El Faro treatment.
Primary Outcome
An 18-item questionnaire with a 4-point Likert scale ranging from Never or Rarely (0) - Very Often (3). With a total score range of 0 -54. A lower score indicated a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL El Faro Treatment Intervention
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
What the finished NCT05928182 record still lists
NCT05928182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which El Faro Treatment Intervention is the first listed.
NCT05928182 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05928182 about?
NCT05928182 is a clinical study titled "El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham". Study team members from El Futuro in Durham, North Carolina have created an intervention called El Faro. El Faro helps Latinx families of children with ADHD understand and cope with the stress and difficulties presented by the disorder. We propose to develop a community-engaged research partnership ...
What is the current status of trial NCT05928182?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-10-10. Estimated completion is 2024-05-30.
What conditions does trial NCT05928182 study?
This clinical trial studies the following conditions: ADHD, Psychiatric Health.
What interventions are being tested in trial NCT05928182?
The interventions under investigation include: El Faro Treatment Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05928182?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928182 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05928182's enrollment target sits among peer trials
32 60th of 75 higher than 16 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI